Policy Change Opportunity: The White House's Executive Order advancing cannabis rescheduling marks a significant step in U.S. federal cannabis reform in over 50 years, potentially opening new avenues for High Tide's business expansion.
Medical Product Development: High Tide's brands, NuLeaf Naturals and FAB CBD, are developing Medicare-aligned product categories aimed at capturing market share by meeting the needs of Medicare Advantage supplemental benefits.
Market Potential Assessment: With approximately four million U.S. customers already in its database, High Tide demonstrates significant long-term growth potential in both federally compliant CBD and regulated cannabis markets.
Investor Relations Re-engagement: High Tide has re-engaged IR Agency for a one-year term at a fee of $140,000 per month, aimed at enhancing communication with investors and improving the company's image in the capital markets.
HITI
$2.79+Infinity%1D
Analyst Views on HITI
Wall Street analysts forecast HITI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HITI is 5.88 USD with a low forecast of 5.00 USD and a high forecast of 7.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast HITI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HITI is 5.88 USD with a low forecast of 5.00 USD and a high forecast of 7.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 2.760
Low
5.00
Averages
5.88
High
7.50
Current: 2.760
Low
5.00
Averages
5.88
High
7.50
Canaccord
Luke Hannan
resume
$7.25
2025-09-24
Reason
Canaccord
Luke Hannan
Price Target
$7.25
2025-09-24
resume
Reason
Canaccord analyst Luke Hannan resumed coverage of High Tide with a Buy rating and C$7.25 price target. The firm believes the company's retail-first model and 2.15M loyalty members provide "superior" unit economics and recurring traffic in competitive Canadian markets. High Tide's margin expansion from white-label brands and its international expansion are catalysts for the shares, the analyst tells investors in a research note.
Roth Capital
Buy
maintain
$5
2025-06-19
Reason
Roth Capital
Price Target
$5
2025-06-19
maintain
Buy
Reason
Roth Capital raised the firm's price target on High Tide to $5 from $4.50 and keeps a Buy rating on the shares. The company reported in-line revenue but beat consensus adjusted EBITDA and showed accelerating same-store sales, while also highlighting ongoing supply/demand improvements within the Canadian market, the analyst tells investors in a research note.
About HITI
High Tide Inc. is a retail-focused cannabis company. The Company’s segments include Bricks-and-mortar and E-commerce. Its Bricks-and-mortar segment includes the Company’s Canadian bricks-and-mortar locations. Its E-commerce segment includes the Company’s United States and international subsidiaries which sell cannabidiol (CBD) and consumption accessories. The Company operates 194 of its branded retail cannabis stores under the Canna Cabana brand, and two branded cannabis stores under the Meta Cannabis Supply Co brand, in addition to its Canadian warehouse operations which primarily service the retail locations in Canada. The Company operates its e-commerce platforms, including Smoke Cartel, Grasscity, Daily High Club, DankStop, NuLeaf Naturals and FABCBD, as well as USA sales on the international e-commerce platforms in the United States. In addition, the Company operates a warehouse which primarily services the e-commerce consumption accessories operations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
